Press Releases

Company News
  Acura Pharmaceuticals Reports 2nd Qtr 2011 Financial Results And Product Development Update
Jul 28, 2011
PDF 34.3 KB Add to Briefcase
  Robert Jones Appointed President & CEO And To The Board Of Directors Of Acura Pharmaceuticals, Inc.
Jul 11, 2011
PDF 20.0 KB Add to Briefcase
  Acura Pharmaceuticals, Inc. Announces The Retirement Of William A. Sumner From Board Of Directors
Jul 8, 2011
PDF 21.4 KB Add to Briefcase
  Acura Pharmaceuticals Receives $20 Million Milestone Payment
Jul 1, 2011
PDF 27.1 KB Add to Briefcase
  Pfizer And Acura Announce FDA Approval Of Oxecta™ (oxycodone HCl, USP) CII
Jun 20, 2011
PDF 134.5 KB Add to Briefcase
  Acura Pharmaceuticals, Inc. Announces Notice Of Allowance For Third Aversion® Technology Patent
Jun 6, 2011
PDF 24.1 KB Add to Briefcase
  Acura Pharmaceuticals, Inc. Announces Appointment Of Robert Jones As Interim President & CEO
May 2, 2011
PDF 23.9 KB Add to Briefcase
  Acura Pharmaceuticals, Inc. Announces The Passing Of Andrew Reddick, President & CEO
Apr 29, 2011
PDF 23.4 KB Add to Briefcase
  Acura Pharmaceuticals Reports First Quarter 2011 Financial Results And Product Development Update
Apr 28, 2011
PDF 28.3 KB Add to Briefcase
  Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave
Apr 25, 2011
PDF 23.9 KB Add to Briefcase
  Acura Pharmaceuticals Reports Year-End And Fourth Quarter 2010 Financial Results And Product Development Update
Mar 1, 2011
PDF 31.0 KB Add to Briefcase
  ACUROX® Tablets New Drug Application Accepted For Filing With A Priority Review Classification
Feb 14, 2011
PDF 33.3 KB Add to Briefcase
Showing 121-132 of 132 Page: 1 ... 3 4 5 6 7  Previous 20
Add to Briefcase = add release to Briefcase